Citigroup Inc Clear Point Neuro, Inc. Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Citigroup Inc holds 9,270 shares of CLPT stock, worth $97,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,270
Previous 300
2990.0%
Holding current value
$97,705
Previous $3,000
3566.67%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding CLPT
# of Institutions
102Shares Held
7.91MCall Options Held
116KPut Options Held
46.8K-
Vanguard Group Inc Valley Forge, PA1.48MShares$15.5 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$6.59 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$3.86 Million0.0% of portfolio
-
State Street Corp Boston, MA333KShares$3.51 Million0.0% of portfolio
-
Morgan Stanley New York, NY332KShares$3.5 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $258M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...